The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Achieve Life Sciences Inc shares valued at $28,887 were purchased by Oki Mark K on Mar 17 ’25. At $2.89 per share, Oki Mark K acquired 10,000 shares. The insider’s holdings grew to 10,000 shares worth approximately $38300.0 following the completion of this transaction.
Also, Stewart Richard Alistair purchased 10,000 shares, netting a total of over 28,598 in proceeds. Following the buying of shares at $2.86 each, the insider now holds 60,876 shares.
As published in their initiating research note from Rodman & Renshaw on November 14, 2024, Achieve Life Sciences Inc [ACHV] has been a Buy and the price target has been revised to $12. Analysts at Raymond James started covering the stock with ‘”a Strong buy”‘ outlook in a report released in late September. As of May 10, 2023, Maxim Group has reiterated its “Buy” rating for ACHV. Earlier on June 23, 2021, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for ACHV stock.
Analyzing ACHV Stock Performance
During the last five days, there has been a surge of approximately 21.59%. Over the course of the year, Achieve Life Sciences Inc shares have jumped approximately 8.81%. Shares of the company reached a 52-week high of $4.30 on 06/03/25 and a 52-week low of $1.84 on 04/09/25.
Support And Resistance Levels for Achieve Life Sciences Inc (ACHV)
According to the 24-hour chart, there is a support level at 3.66, which, if violated, would cause prices to drop to 3.50. In the upper region, resistance lies at 4.14. The next price resistance is at 4.46. RSI (Relative Strength Index) is 66.07 on the 14-day chart, showing neutral technical sentiment.
